2-Thiophenecarbonyl chloride → Tert-butyl 4-(5-(2-thienyl)-1,2,4-oxadiazol-3-yl)piperazine-1-carboxylate
反応式
[OH:1][NH:2][C:3](=[NH:17])[N:4]1[CH2:9][CH2:8][N:7]([C:10]([O:12][C:13]([CH3:16])([CH3:15])[CH3:14])=[O:11])[CH2:6][CH2:5]1.[S:18]1[CH:22]=[CH:21][CH:20]=[C:19]1[C:23](Cl)=O.CCN(C(C)C)C(C)C>C(Cl)Cl>[S:18]1[CH:22]=[CH:21][CH:20]=[C:19]1[C:23]1[O:1][N:2]=[C:3]([N:4]2[CH2:5][CH2:6][N:7]([C:10]([O:12][C:13]([CH3:14])([CH3:16])[CH3:15])=[O:11])[CH2:8][CH2:9]2)[N:17]=1参加物
実験手順
To a cold (0° C.) solution of tert-butyl 4-[(hydroxyamino)(imino)methyl]piperazine-1-carboxylate (8 g, 32.7 mmol) in anhydrous DCM (150 mL) was added thiophene-2-carbonyl chloride (4.8 g, 32.7 mmol) followed by DIEA (7.2 mL, 39.2 mmol). The reaction mixture was stirred at RT for 12 hours and then filtered. The filtrate was evaporated and the residue was refluxed in pyridine (100 mL) for 3 hours. The solvent was removed under vacuum and the residue was dissolved in DCM. The organic layer was washed with a 10% aq. solution of sodium bicarbonate, water, brine and dried. The solvent was concentrated and the residue was purified by chromatography (Pet. Ether/EtOAc 7/3) to give 2.2 g (20%) of The title compound as a solid. TLC-Pet ether/EtOAc (9/1): Rf=0.75. HPLC purity>97%.
後処理
- filtrationfiltered
- customThe filtrate was evaporated
- temperaturethe residue was refluxed in pyridine (100 mL) for 3 hours
- customThe solvent was removed under vacuum
- dissolutionthe residue was dissolved in DCM
- washThe organic layer was washed with a 10% aq. solution of sodium bicarbonate, water, brine
- customdried
- concentrationThe solvent was concentrated
- customthe residue was purified by chromatography (Pet. Ether/EtOAc 7/3)
出典と根拠
- ORDレコード
- ord-c015abd082ed4c13a5b11d2757071805
- 出典データセット
- uspto-grants-2012_08
- 特許番号
- US08247437B2
反応ノート
読み込み中…